Pharmacologic therapies for acutely decompensated heart failure

Reviews in Cardiovascular Medicine

Volumn 3, Issue SUPPL. 4, 2002, Pages

  Fonarow, Gregg C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute heart failure; Emergency department; Hemodynamics; Vasodilators

Indexed keywords

ADRENALIN; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENOXIMONE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; INOTROPIC AGENT; ISOPRENALINE; MILRINONE; MORPHINE SULFATE; NALOXONE; NESIRITIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PIPERANOMETOZINE; VASODILATOR AGENT; XAMOTEROL;

ACUTE HEART FAILURE; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG HALF LIFE; DRUG MECHANISM; DYSPNEA; EMERGENCY WARD; FATALITY; HEADACHE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HORMONAL REGULATION; HUMAN; HYPOTENSION; HYPOXEMIA; INOTROPISM; LUNG EDEMA; LUNG WEDGE PRESSURE; PATHOPHYSIOLOGY; PREDICTION; SUDDEN DEATH; SURVIVAL; SYMPTOMATOLOGY; TACHYPHYLAXIS; TISSUE PERFUSION; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATATION;

CARDIOTONIC AGENTS; DIURETICS; EMERGENCY TREATMENT; HEART FAILURE, CONGESTIVE; HUMANS; MORPHINE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; VASODILATOR AGENTS;

EID: 0036382030     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cordial. 2001;38:2101-2113.
2. American Heart Association. 2002 Heart and Stroke Statistical Update, Dallas, TX: American Heart Association 2001
3. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628-640.
4. Cody R. Clinical trials of diuretic therapy in heart failure: research directions and clinical considerations. J Am Coll Cardiol. 1993;22(4 suppl A): 16SA-171A.
5. Fonarow GC. The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med. 2001;2:7-12.
6. Gandhi SK, Powers JC, Nomier AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001,344:17-22.
7. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987;60:654-658.
8. Fonarow GC, Hamilton MA, Moriguchi J, et al. Hemodynamic predictors of clinical outcomes in decompensated advanced heart failure. J Card Fail. 2001;7:038.
9. Rosario LB, Stevenson LW, Solomon SD, et al. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol. 1998;32:1819-1824.
10. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol. 1990;16:1125-1134.
11. Stevenson LW, Tillisch JH, Hamilton M, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1990;66:1348-1354.
12. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386-391.
13. Kubo SH, Clark M, Laragh JH, et al. Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. Am J Cardiol. 1987;60:1322-1328.
14. Cotter G, Metzkor E, Kaluski E, et al. Randomized trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema. Lancet. 1998,351:389-393.
15. Sacetti A, Ramoska E, Moakes ME, et al. Effect of ED management on ICU use in acute pulmonary edema. Am J Emerg Med. 1999,6:571-574.
16. Ewy GA. Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals? J Am Coll Cardiol. 1999;33:572-575.
17. Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure. JAMA. 2002;287:1541-1547.
18. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol. 1992;19:842-850.
19. Steimle AE, Stevenson LW, Chelinisky-Fallick C, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation. 1997;96:1165-1172.
20. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-733.
21. VMAC Investigators. Intravenous nesiritide vs nitroglycerine for treatment of decompensated congestive heart failure. JAMA. 2002;287:1531-1540.
22. Elkayam U, Johnson JV, Shotan A, et al. Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition. Circulation. 1999;99:2652-2657.
23. Colucci WS, Elkayam U, Horton DP, et al, for the Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246-253.
24. Burger AJ. Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol. 2001;88:35-39.
25. Silver MA, Horton DP, Ghali JK, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 1997;39:798-803.